The Dexcom G7 15-day sensor extends wear from 10 days to 15 days on the same hardware platform. It received FDA 510(k) clearance in late 2024 (K243213) and began shipping to US patients in early 2025. Accuracy is reported as comparable to the original 10-day G7, sensor list price is unchanged, and the upgrade requires no new prescription or app.
What Changed and What Did Not
The 15-day G7 wearable looks and applies identically to the 10-day. The same applicator, same back-of-arm site, same 30-minute warmup, same Bluetooth pairing flow. Three things changed:
- Algorithm: Refined glucose-conversion firmware to maintain accuracy through day 15.
- Enzyme stability: Manufacturing improvements extended the working life of the glucose oxidase coating.
- Labeling: FDA-cleared wear time updated from 10 days plus 12-hour grace period to 15 days plus 12-hour grace period.
For a complete primer on how G7 works in general — the filament, the transmitter, the integrations — see our flagship Dexcom G7 reference.
Side-by-Side: G6, G7 10-Day, G7 15-Day
| Feature | Dexcom G6 | Dexcom G7 10-Day | Dexcom G7 15-Day |
|---|---|---|---|
| FDA clearance | 2018 | Dec 2022 | Late 2024 |
| Wear time | 10 days | 10 days + 12 hr grace | 15 days + 12 hr grace |
| Warmup | 2 hours | 30 minutes | 30 minutes |
| Form factor | Sensor + transmitter | All-in-one | All-in-one (same as 10-day) |
| MARD | ~9.0% | ~8.2% | ~8 to 9% (Dexcom-reported) |
| Wear site | Abdomen | Back of upper arm | Back of upper arm |
| Integration with AID pumps | Yes | Yes | Yes |
Accuracy on the Extended Days
Historical concern with longer-wear CGMs has been accuracy drift on later days as the enzyme degrades and the local foreign-body response changes. Dexcom’s submitted data for the 15-day G7 show MARD on days 11 through 15 within roughly 1 percentage point of MARD on days 1 through 10. The difference is not clinically meaningful for routine dosing decisions.
An independent peer-reviewed publication is expected after the full rollout. Until then, the data of record are the FDA submission and Dexcom’s own pivotal study report. Both place 15-day G7 in the same accuracy tier as Eversense 365 and FreeStyle Libre 3.
Cost Implications
Sensor list price did not increase with the wear-time extension. A box of three sensors that previously delivered 30 days of wear now delivers 45 days. For cash-pay users, that is a roughly 33 percent reduction in cost per day. For insured users, the impact varies by plan structure — some plans bill per box, others per 30-day supply, and a few specify per-sensor billing.
| Coverage Type | Likely Effect of 15-Day Switch |
|---|---|
| Cash pay | ~33% lower cost per day |
| Pharmacy benefit, per-box copay | Same copay, longer wear per box |
| DME benefit, 90-day shipment | Fewer sensors per shipment, same coinsurance |
| Medicare Part B | Adjusted to match 15-day wear; minimal patient impact |
Rollout Timing
Dexcom announced US shipments of 15-day G7 sensors beginning in Q1 2025, with full inventory turnover at major distributors expected by mid-to-late 2025. Pharmacies and direct-to-consumer fulfillment centers ship whatever they have in stock, so users may receive 10-day or 15-day boxes during the transition. International rollout follows on a country-by-country regulatory schedule.
Do You Need to Do Anything?
For most users, no. The same Dexcom G7 prescription covers both wear-time versions. The same G7 app receives an automatic firmware update that recognizes 15-day sensors. Smart watch and pump compatibility is unchanged. The only practical change is that the app countdown reads “15 days” instead of “10 days” once you scan a 15-day sensor.
What This Does Not Change
- Wear site (still back of upper arm; upper buttocks for pediatric ages 2 to 6).
- 30-minute warmup at sensor start.
- Sensor adhesive and overpatch options.
- Compatibility with Stelo (separate over-the-counter product), the Tandem t:slim X2, Omnipod 5, iLet, and Tandem Mobi.
- The 12-hour grace period after expiration.
Practical Tips for the Switch
- If you receive a mixed shipment during transition, use the 10-day sensors first to keep your reorder schedule predictable.
- Reset any reminders you use (calendar alarms, pill-bottle countdown apps) to a 15-day cadence once you switch.
- If your pharmacy bills per 30-day supply, ask whether your refill cadence will adjust automatically or whether you need a new prescription quantity.
- Inspect the sensor area daily as you would on the 10-day. Adhesive and skin reactions can develop later in extended-wear sessions.
How This Fits Your Care Plan
Continuous glucose monitoring is most useful when paired with broader self-management — diet patterns documented in our diet and nutrition guide and the treatment overview, plus regular communication with your clinician. The wear-time extension makes day-to-day use a little more convenient and a little less expensive but does not change the underlying clinical picture.
The Bottom Line
The Dexcom G7 15-day sensor is the same wearable, with smarter firmware and validated extended wear. Accuracy holds, price holds, and you get 50 percent more days per sensor. If you are already on G7, the switch is automatic when your pharmacy stock turns over. If you are evaluating CGMs for the first time, this rollout makes G7 cheaper per day than it has ever been.
